You are here

AbbVie

AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study

Fierce Pharma

Thu, 08/29/24 - 06:06 pm

clinical trials

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Reuters

Mon, 08/26/24 - 10:14 pm

BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings

Pharma Voice

Mon, 08/19/24 - 09:58 am

Bristol Myers Squibb

Skyrizi soars to top of Rx, OTC pharma brand rankings in July

Medical Marketing and Media

Tue, 08/13/24 - 11:25 am

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth

Fierce Pharma

Fri, 08/9/24 - 11:25 am

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations

BioSpace

Mon, 08/5/24 - 11:21 am

Ribon Therapeutics

PARP inhibitors

AbbVie Completes Acquisition Of Cerevel; Reaffirms Full-year Adj. EPS Guidance Range

NASDAQ

Thu, 08/1/24 - 11:52 am

AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff

BioSpace

Mon, 07/29/24 - 10:31 am

ulcerative colitis

AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs

Yahoo/Benzinga

Thu, 07/25/24 - 11:30 am

AbbVie axes midstage Alzheimer's program amid 'evolving landscape'

Fierce Biotech

Thu, 07/25/24 - 11:30 am

Alzheimer's disease

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

BioPharma Dive

Tue, 07/16/24 - 12:06 pm

Sionna Therapeutics

cystic fibrosis

Vertex Pharmaceuticals

5 Neuro Data Readouts to Watch in the Second Half of 2024

BioSpace

Mon, 07/15/24 - 11:43 am

clinical trials

Alzheimer's disease

Cerevel Therapeutics

Neumora Therapeutics

major depressive disorder

Wolfram syndrome

Vigil Neuroscience

AbbVie led the way in paying doctors to pitch its drugs last year

Axios

Mon, 07/15/24 - 09:57 am

physician payments

AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis

Managed Healthcare Executive

Sun, 07/14/24 - 10:12 pm

giant cell arteritis

AbbVie’s Humira continues to lose market share as biosimilars gain ground

BioSpace

Fri, 07/12/24 - 11:35 am

AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit

Fierce Pharma

Thu, 07/11/24 - 11:02 pm

Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections

Pharma Voice

Fri, 06/28/24 - 11:17 am

Prothena Biosciences

Bristol Myers Squibb

AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave

Fierce Biotech

Thu, 06/27/24 - 11:27 am

Celsius Therapeutics

Pages